This investigation or therapeutic intervention is of minimal gain for patients and might be done. In the event of pT2 pN0 a taxane dependent polychemotherapy as well as trastuzumab monotherapy is suggested which could be followed in case of a HR+ tumor by neratinib monotherapy for as much as https://norahb075udm3.izrablog.com/profile